Dr. David Samadi Says Inflammation Promotes Progression Of Prostate Cancer

Posted on April 05, 2018

According to world-renown urological doctor, Dr. David Samadi, chronic inflammation within the body unite many different health problems, including prostate cancer. Benign Prostatic Hyperplasia is the most frequently diagnosed urological pathology in men aged 50+ years. In fact, in three out of four patients with BPH there is a chronic inflammation that triggers the symptoms and promotes the progression of the disease. Just like when an insect stings, we take a bacterium or we have an allergic reaction, in the same way when the prostate is triggered by an acute inflammation. It’s one of the reasons Dr. David Samadi shines light on foods that naturally help your body’s defense mechanisms.

Foods Are Powerful Antioxidants

Lycopene is a particularly effective antioxidant, and twice as potent as beta carotene and ten times more than alpha tocopherol. Lycopene is also concentrated in some organs and, in particular, in the prostate. Studies have shown lower incidence of prostate cancer in populations that consume large quantities of tomato and tomato derivatives.
Researchers have reported that, in vitro, lycopene, associated with vitamin E, inhibits the growth of two different types of prostate cancer cells, and several studies have linked lycopene to a lower risk of cancer. One study revealed that men with higher blood lycopene concentrations present half the risk of contracting prostate cancer than those with lower concentrations.

Overall, the low consumption of foods and supplements rich in antioxidant compounds is associated with increased aggressiveness of prostate cancer. According to Dr. Samadi, adequate nutrition and the use of antioxidant-based supplements may represent a strategy to counteract the worsening of this widespread tumor.

During the past 20+ years, Dr. David Samadi has often considered the major and minor contributions of food, and how it impacts chronic disease. He’s one of the top minds and recognized experts in prostate cancer and robotic surgery. He is also known for his innovative SMART surgery techniques, which are less invasive, requires less surgical time, and a quicker recovery.

Dr. Samadi immigrated from Iran to London, then to New York. He grew up in Rosslyn New York, attended Stony Brook University, then completed his post-graduate internship and residency locally, at Montifiore Hospital, then Albert Einstein Hospital, both in the Bronx. Dr. Samadi also completed an oncology fellowship at Memorial Sloan Kettering Cancer Center.

From New York’s Columbia Presbyterian Hospital to Mount Sinai Medical Center to Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital, Dr. David Samadi has become an internationally renowned surgeon with extensive surgery experience.

Read More: prostatecancer911.com/david-samadi/